Epidemiology of cardiovascular disease in China: current features and implications-Reference-Cited by-同舟云学术

Epidemiology of cardiovascular disease in China: current features and implications

Published:2018-11-22 Issue:4 Volume:16 Page:203-212
ISSN:1759-5002
Container-title:Nature Reviews Cardiology
language:en
Short-container-title:Nat Rev Cardiol

Author:

Zhao Dong,Liu Jing,Wang Miao,Zhang Xingguang,Zhou Mengge

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://www.nature.com/articles/s41569-018-0119-4.pdf

Reference79 articles.

1. Zhou, M. et al. Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet 387, 251–272 (2016).

2. Yang, G. et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 381, 1987–2015 (2013).

3. National Center for Cardiovascular Diseases. Report on Cardiovascular Diseases in China 2017 [Chinese] (Encyclopedia of China Publishing House, 2017).

4. Institute for Health Metrics and Evaluation (IHME). GBD Compare | Viz Hub. VizHub http://vizhub.healthdata.org/gbd-compare (2018).

5. Wright, P. Yingkai Wu–obituary. Lancet 363, 575–575 (2004).

Cited by 820 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of Panax ginseng and its active ingredients protective mechanism on cardiovascular diseases;Journal of Ethnopharmacology;2024-11

2. A quantitative study of the effects of a dual layer coating drug-eluting stent on safety and efficacy;Journal of Biomechanics;2024-11

3. Epigenetic regulation of diverse regulated cell death modalities in cardiovascular disease: Insights into necroptosis, pyroptosis, ferroptosis, and cuproptosis;Redox Biology;2024-10

4. Near-infrared-triggered plasmonic regulation and cardiomyocyte-based biosensing system for in vitro bradyarrhythmia treatment;Biosensors and Bioelectronics;2024-10

5. Interference with GPR4 inactivates NLRP3 inflammasome signaling by inhibiting LPAR1 expression to ameliorate oxygen-glucose deprivation/reoxygenation-induced inflammation and apoptosis of cardiomyocytes;Prostaglandins & Other Lipid Mediators;2024-10